Synergistic effect of 5-HT1A and σ1 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency

Neuropharmacology

Volumn 75, Issue , 2013, Pages 53-61

  Hiramatsu, Naoki ^a   Ago, Yukio ^a   Hasebe, Shigeru ^a   Nishimura, Akira ^a   Mori, Kazuya ^a   Takuma, Kazuhiro ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Adrenalectomy; Castration; Dopamine; Prefrontal cortex

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; AZASETRON; BRAIN MONOAMINE; DOPAMINE; FLUVOXAMINE; N ALLYLNORMETAZOCINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OSEMOZOTAN; PROTEIN C FOS; RITANSERIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SIGMA 1 OPIATE RECEPTOR;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG POTENTIATION; GENE EXPRESSION; IMMUNOREACTIVITY; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PREFRONTAL CORTEX; PRIORITY JOURNAL; VENTRAL TEGMENTUM;

ADRENALECTOMY; CASTRATION; DOPAMINE; PREFRONTAL CORTEX; SEROTONIN(1A) RECEPTOR; Σ(1) RECEPTOR;

ADRENALECTOMY; ANIMALS; CASTRATION; DOPAMINE; DRUG SYNERGISM; MALE; MICE; MICE, INBRED STRAINS; PHENAZOCINE; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, SIGMA; SEROTONIN AGENTS; STEROIDS; VENTRAL TEGMENTAL AREA;

EID: 84882948921     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.06.026     Document Type: Article

References (53)

1. R.C. Agís-Balboa, G. Pinna, A. Zhubi, E. Maloku, M. Veldic, E. Costa, and A. Guidotti Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis Proc. Natl. Acad. Sci. U. S. A. 103 2006 14602 14607 (Pubitemid 44484796)
2. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex Neuropharmacology 45 2003 1050 1056 (Pubitemid 37412250)
3. Y. Ago, S. Nakamura, A. Hayashi, S. Itoh, A. Baba, and T. Matsuda Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice Pharmacol. Biochem. Behav. 85 2006 198 205 (Pubitemid 44772921)
4. Y. Ago, S. Nakamura, N. Kajita, M. Uda, H. Hashimoto, A. Baba, and T. Matsuda Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice Synapse 61 2007 757 763 (Pubitemid 47122748)
5. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice Neuropharmacology 51 2006 914 922 (Pubitemid 44376402)
6. 1 receptor activation Psychopharmacology (Berl) 217 2011 377 386
7. K.D. Alex, and E.A. Pehek Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission Pharmacol. Ther. 113 2007 296 320 (Pubitemid 46149046)
8. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons Naunyn-Schmiedeberg's Arch. Pharmacol. 347 1993 353 362 (Pubitemid 23128605)
9. T. Aubele, and M.F. Kritzer Gonadectomy and hormone replacement affects in vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats Cereb. Cortex 21 2011 222 232
10. N.H. Chen, and M.E. Reith Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin J. Neurochem. 64 1995 1585 1597
11. E.J. Cobos, J.M. Entrena, F.R. Nieto, C.M. Cendán, and E. Del Pozo Pharmacology and therapeutic potential of sigma1 receptor ligands Curr. Neuropharmacol. 6 2008 344 366
12. C. Corpéchot, J. Young, M. Calvel, C. Wehrey, J.N. Veltz, G. Touyer, M. Mouren, V.V.K. Prasad, C. Banner, J. Sjövall, E.E. Baulieu, and P. Robel Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats Endocrinology 133 1993 1003 1009 (Pubitemid 23267748)
13. L. Dazzi, M. Serra, E. Seu, G. Cherchi, M.G. Pisu, R.H. Purdy, and G. Biggio Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride J. Neurochem. 83 2002 1103 1109 (Pubitemid 35397120)
14. L. Dazzi, M. Serra, G. Vacca, S. Ladu, A. Latrofa, G. Trapani, and G. Biggio Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output Brain Res. 932 2002 135 139 (Pubitemid 34241604)
15. M.A. Fox, C.L. Jensen, P.S. Gallagher, and D.L. Murphy Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice Neuropharmacology 53 2007 643 656 (Pubitemid 47513171)
16. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press, Inc. San Diego
17. M.S. George, A. Guidotti, D. Rubinow, B. Pan, K. Mikalauskas, and R.M. Post CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI Biol. Psychiatry 35 1994 775 780 (Pubitemid 24164999)
18. R.J. Handa, G.M. Hejna, and S.A. Lorens Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment Brain Res. 751 1997 131 138 (Pubitemid 27122144)
19. K. Hashimoto, Y. Fujita, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors Neuropsychopharmacology 32 2007 514 521
20. 1 receptor ligand Expert Opin. Ther. Targets 12 2008 45 58 (Pubitemid 351247161)
21. T. Hayashi, and T.P. Su σ-1 receptor ligands: potential in the treatment of neuropsychiatric disorders CNS Drugs 18 2004 269 284 (Pubitemid 38526712)
22. 7 receptors contribute to lurasidone-induced dopamine efflux Neuroreport 23 2012 436 440
23. T. Kobayashi, K. Matsuno, K. Nakata, and S. Mita Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain J. Pharmacol. Exp. Ther. 279 1996 106 113 (Pubitemid 27166900)
24. K. Koda, Y. Ago, Y. Cong, Y. Kita, K. Takuma, and T. Matsuda Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice J. Neurochem. 114 2010 259 270
25. F. Labombarda, A. Pianos, P. Liere, B. Eychenne, S. Gonzalez, A. Cambourg, A.F. De Nicola, M. Schumacher, and R. Guennoun Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry Endocrinology 147 2006 1847 1859
26. 1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats J. Pharmacol. Exp. Ther. 280 1997 1241 1249 (Pubitemid 27166720)
27. C.E. Marx, D.W. Bradford, R.M. Hamer, J.C. Naylor, T.B. Allen, J.A. Lieberman, J.L. Strauss, and J.D. Kilts Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence Neuroscience 191 2011 78 90
28. C.E. Marx, M.J. VanDoren, G.E. Duncan, J.A. Lieberman, and A.L. Morrow Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents Neuropsychopharmacology 28 2003 1 13
29. K. Matsuno, K. Matsunaga, T. Senda, and S. Mita Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex J. Pharmacol. Exp. Ther. 265 1993 851 859 (Pubitemid 23315597)
30. K. Matsuno, T. Senda, T. Kobayashi, and S. Mita Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats Brain Res. 690 1995 200 206
31. 1 receptor function: behavioral consequences and therapeutic opportunities Brain Res. Rev. 37 2001 116 132 (Pubitemid 34020726)
32. R.C. Melcangi, G. Panzica, and L.M. Garcia-Segura Neuroactive steroids: focus on human brain Neuroscience 191 2011 1 5
33. S.H. Mellon, and L.D. Griffin Neurosteroids: biochemistry and clinical significance Trends Endocrinol. Metab. 13 2002 35 43 (Pubitemid 36734014)
34. K. Nakamura, K. Suzuki, A.C. McCreary, and C.R. Ashby Jr. The acute and chronic administration of (±)-8-hydroxy-2-(di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study Synapse 59 2006 359 367
35. N. Narita, K. Hashimoto, S. Tomitaka, and Y. Minabe Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain Eur. J. Pharmacol. 307 1996 117 119 (Pubitemid 26226293)
36. National Research Council Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, DC
37. T. Niitsu, M. Iyo, and K. Hashimoto Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases Curr. Pharm. Des. 18 2012 875 883
38. N. Orentreich, J.L. Brind, R.L. Rizer, and J.H. Vogelman Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J. Clin. Endocrinol. Metab. 59 1984 551 555 (Pubitemid 14031806)
39. V.L. Phan, T.P. Su, A. Privat, and T. Maurice Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect σ1 receptor-mediated behaviour in mice Eur. J. Neurosci. 11 1999 2385 2396 (Pubitemid 29292333)
40. J.P. Redrobe, and M. Bourin Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test Psychopharmacology (Berl) 138 1998 198 206 (Pubitemid 28330838)
41. C.E. Renard, A.J. Fiocco, F. Clenet, M. Hascoet, and M. Bourin Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology (Berl) 159 2001 42 50 (Pubitemid 34031249)
42. A. Ströhle, E. Romeo, B. Hermann, A. Pasini, G. Spalletta, F. di Michele, F. Holsboer, and R. Rupprecht Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery Biol. Psychiatry 45 1999 274 277 (Pubitemid 29100030)
43. A. Ströhle, A. Pasini, E. Romeo, B. Hermann, G. Spalletta, F. di Michele, F. Holsboer, and R. Rupprecht Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression J. Psychiat. Res. 34 2000 183 186 (Pubitemid 30364917)
44. 7 receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders J. Mol. Neurosci. 48 2012 473 481
45. 1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test J. Pharmacol. Exp. Ther. 298 2001 1269 1279 (Pubitemid 32761949)
46. 1) receptor agonist igmesine involves modulation of intracellular calcium mobilization Psychopharmacology (Berl) 163 2002 26 35 (Pubitemid 34985309)
47. F. van Broekhoven, and R.J. Verkes Neurosteroids in depression: a review Psychopharmacology (Berl) 165 2003 97 110 (Pubitemid 36056986)
48. V. Viau, A. Chu, L. Soriano, and M.F. Dallman Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release J. Neurosci. 19 1999 6684 6693 (Pubitemid 29347468)
49. 7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats Pharmacol. Rep. 60 2008 464 474
50. O.M. Wolkowitz, V.I. Reus, A. Keebler, N. Nelson, M. Friedland, L. Brizendine, and E. Roberts Double-blind treatment of major depression with dehydroepiandrosterone Am. J. Psychiatry 156 1999 646 649 (Pubitemid 29162992)
51. O.M. Wolkowitz, V.I. Reus, E. Roberts, F. Manfredi, T. Chan, W.J. Raum, S. Ormiston, R. Johnson, J. Canick, L. Brizendine, and H. Weingartner Dehydroepiandrosterone (DHEA) treatment of depression Biol. Psychiatry 41 1997 311 318 (Pubitemid 27095256)
52. R. Yehuda, and J. Seckl Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis Endocrinology 152 2011 4496 4503
53. P. Zheng Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance Prog. Neurobiol. 89 2009 134 152